⚕️ This educational content is intended exclusively for licensed physicians and aesthetic-medicine clinics. It is provided for professional information only and is not promotional material directed at the general public.
Introduction
The evolution of bioregenerative aesthetic medicine has shifted clinical focus from volumizing correction to cellular restoration and tissue quality improvement.
Among the most advanced formulations within this new paradigm stands Nouveau Visage Newderm Age Control, a professional-grade treatment designed to reverse early signs of aging, enhance dermal vitality, and rebuild extracellular integrity through Exosomes Biomimetic Therapy.
Developed for medical use, Newderm Age Control delivers a targeted combination of exosomes, polynucleotides, biomimetic peptides, and hyaluronic acid. Together, these actives create a regenerative cascade that stimulates fibroblast activity, promotes collagen renewal, and restores deep hydration — all while maintaining biocompatibility and safety standards suited to clinical practice.
Official source: https://www.nouveau-visage.com/produit/newderm-age-control/
Scientific Background: Exosomes and Biomimetic Peptides in Regenerative Aesthetics
Recent studies in regenerative dermatology have identified exosomes as natural carriers of signaling molecules, capable of orchestrating tissue repair through paracrine communication. Derived from stem-cell cultures or botanically engineered sources such as Centella Asiatica, exosomes transport proteins, growth factors, and nucleic acids that directly modulate dermal cell behavior.
Parallel to this discovery, biomimetic peptides—short amino-acid chains replicating endogenous sequences—have been formulated to mimic the activity of naturally occurring growth factors. When combined, exosomes and peptides form a synergistic system that addresses both structural and metabolic dimensions of skin aging: exosomes provide the biological stimulus, while peptides translate that message into collagen and elastin synthesis.
This dual-action approach underlies Nouveau Visage’s Exosomes Biomimetic Therapy, featured prominently in the Newderm professional line.
Composition and Mechanism of Action
1. Polynucleotides (PDRN)
Polynucleotides are DNA fragments extracted from salmon-trout sperm cells that serve as metabolic substrates for dermal regeneration.
They activate the A2A adenosine receptor pathway, enhancing fibroblast proliferation, angiogenesis, and the synthesis of hyaluronic acid.
→ Reference: Cavallini M et al. Polynucleotides in Aesthetic Medicine: Biorestructuring and Skin Regeneration. Aesthetic Medicine 2018.
https://pubmed.ncbi.nlm.nih.gov/30382454/
2. Hyaluronic Acid (HA)
A non-crosslinked HA at 24 mg/ml provides immediate hydration and supports extracellular architecture. By restoring the intercellular water network, HA improves elasticity and optimizes the diffusion of other bioactive components.
→ Reference: Juhász MLW, Cohen JL. The Science of Hyaluronic Acid Fillers. Aesthetic Surgery Journal 2020.
https://pubmed.ncbi.nlm.nih.gov/32678804/
3. Exosomes from Centella Asiatica
These vesicles deliver antioxidant enzymes and micro-RNAs that reduce inflammatory cytokines and stimulate collagen I and III gene expression. Their nanoscale size allows penetration to the papillary dermis, where they enhance tissue communication and repair.
→ Reference: Zhang Y et al. Exosomes: Biogenesis, Biologic Function, and Clinical Potential. Cell & Bioscience 2019.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6397026/
4. Biomimetic Peptides
Peptides such as Palmitoyl Tetrapeptide-72, Acetyl Hexapeptide-1, and Oligopeptide-24 emulate natural sequences like TGF-β or fibroblast growth factors. They regulate extracellular-matrix renewal, protect against glycation, and smooth fine lines through neuromuscular modulation.
→ Reference: Schagen SK. Topical Peptides in Anti-Aging Skin Care. Cosmetics 2017; 4(2):16.
https://www.mdpi.com/2079-9284/4/2/16
Synergistic Effect
Together, these components establish a biorestructuring micro-environment:
- Exosomes deliver the regenerative signal.
- Polynucleotides provide metabolic fuel.
- Peptides execute structural remodeling.
- Hyaluronic acid ensures optimal hydration and mechanical support.
The outcome is a progressive, physiological rejuvenation rather than a temporary volumizing effect.
Clinical Indications
Ideal patient profiles:
- Early to moderate chrono- or photo-aging.
- Fine lines, dull complexion, and dehydration.
- Mild skin laxity in the mid-face, neck, or décolletage.
- Post-procedure skin needing regenerative support (after laser, RF, or microneedling).
Contraindications:
- Active infection, inflammation, or autoimmune disease at treatment site.
- Pregnancy or lactation.
- Hypersensitivity to any ingredient.
Target zones:
Face, periorbital region, neck, décolletage, and hands — anywhere dermal quality requires restoration without volumetric filler.
Professional Protocol
| Parameter | Recommendation |
|---|---|
| Presentation | 4 vials × 5 ml (single-use sterile vials) |
| Application technique | Micro-injection into superficial/mid dermis using nappage, micro-papule, or cannula technique |
| Session frequency | Every 2 weeks × 4 sessions (initial cycle) |
| Maintenance | 1 session every 3–4 months |
| Adjunctive therapies | Compatible with microneedling, PRP, RF, laser, or mesogun infusion |
Clinical practice suggests combining Newderm Age Control with a gentle peel or fractional laser one week prior to the first session to enhance penetration and fibroblast responsiveness.
Clinical Outcomes
Early phase (after 1–2 sessions)
- Increase in hydration and radiance.
- Reduction in superficial fine lines.
- Enhanced patient perception of skin softness and glow.
After full cycle (4 sessions)
- Measurable improvement in firmness and elasticity (dermal ultrasound or cutometry).
- Visible reduction in perioral and periorbital wrinkles.
- More even tone and refined texture.
Maintenance phase
Ongoing activation of neocollagenesis maintains long-term skin quality. With proper follow-up, results persist 6–8 months, extending up to a year when reinforced with home protocols such as Le Sérum Newage.
Comparative Advantages in Clinical Practice
| Feature | Benefit for Clinic / Patient |
|---|---|
| Exosomes + Peptides + PDRN synergy | Multidimensional tissue regeneration |
| Non-crosslinked formula | Natural feel and low risk of nodules |
| No volumizing filler effect | Ideal for subtle, global rejuvenation |
| Fast procedure (≈ 20 min) | High patient turnover |
| Minimal downtime | Return to daily activity immediately |
| Long-term dermal remodeling | Improves patient retention and loyalty |
Unlike traditional HA fillers, Newderm Age Control does not rely on mechanical filling but instead stimulates the skin to regenerate itself, aligning with the latest trend of “bio-lifting” rather than “volumizing.”
Integration into Clinical Workflow
- Assessment – Evaluate skin thickness, laxity, and phototype.
- Preparation – Cleanse with antiseptic; optional topical anesthetic.
- Injection – Use micro-papule or mesotherapy gun, spacing points 1 cm apart.
- Post-care – Apply sterile soothing serum or LED therapy for 10 minutes.
- Follow-up – Schedule the next session in 2 weeks.
Educational materials and clinical training are available through authorized distributors or directly via the manufacturer’s website.
https://www.nouveau-visage.com/produit/newderm-age-control/
Safety and Tolerability
Clinical data and in-practice reports show a high safety profile, with only mild transient erythema or edema observed post-injection.
No granulomas or long-term adverse effects have been reported under proper aseptic technique.
To ensure patient safety:
- Use one vial per patient/session.
- Store between 2 °C – 25 °C.
- Avoid mixing with other injectable substances in the same syringe.
- Record batch numbers for traceability (as per EU Medical Device Regulation).
Scientific Evidence Supporting Exosome and PDRN Therapy
- Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020; 367(6478):eaau6977.
https://www.science.org/doi/10.1126/science.aau6977 - Gurunathan S et al. Current trends in therapeutic application of exosomes in regenerative medicine. Int J Nanomedicine. 2021; 16:75–106.
https://pmc.ncbi.nlm.nih.gov/articles/PMC7816837/ - Zhang Y et al. Exosomes: Biogenesis, Biologic Function and Clinical Potential. Cell & Bioscience. 2019.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6397026/ - Cavallini M et al. Polynucleotides in Aesthetic Medicine. Aesthetic Medicine. 2018.
https://pubmed.ncbi.nlm.nih.gov/30382454/
These peer-reviewed studies reinforce the cellular mechanisms harnessed by Newderm Age Control — particularly the stimulation of fibroblast metabolism and extracellular-matrix remodeling.
Regulatory and Professional Considerations
Newderm Age Control is a medical-device-class III injectable intended exclusively for professional use within aesthetic and dermatologic clinics.
It complies with European CE marking standards for sterility, biocompatibility, and manufacturing quality (ISO 13485).
Physicians should document:
- Informed consent referencing exosome-based therapy.
- Lot numbers and expiration dates.
- Clinical notes describing technique and treated zones.
Combining documentation with high-resolution before/after photography enhances transparency and professional credibility.
Patient Education and Communication
When presenting Newderm Age Control to patients:
- Emphasize that results are progressive (visible improvement after several weeks).
- Explain that it works by stimulating natural collagen, not by “filling.”
- Highlight safety and scientific validation.
- Recommend complementary home care such as Le Sérum Newage or Newskin Revitalizing Cream for maintenance.
Educated patients tend to adhere better to full protocols and maintenance schedules, improving long-term satisfaction.
Future Perspectives in Exosome-Based Aesthetic Medicine
The incorporation of exosomes and biomimetic peptides marks a significant evolution toward smart bio-communication therapies.
Future research is exploring exosome customization, targeted peptide delivery, and combination with nanocarriers for even more precise dermal modulation.
For clinicians, integrating exosome-based protocols like Newderm Age Control positions the practice at the forefront of regenerative aesthetics — where skin health and cellular renewal define the future of rejuvenation.
Conclusion
Nouveau Visage Newderm Age Control represents the convergence of biotechnology and clinical aesthetics.
Its formula—merging exosomes, biomimetic peptides, polynucleotides, and hyaluronic acid—enables a regenerative approach that goes beyond traditional injectables.
For the aesthetic practitioner, it offers:
- A scientifically validated mechanism of action.
- Predictable and durable outcomes.
- A premium, differentiating service for discerning patients seeking natural rejuvenation.
Incorporating Newderm Age Control into your practice not only enhances treatment results but also elevates your clinic’s reputation as a center for advanced regenerative medicine.
References
- Nouveau Visage. Newderm Age Control – Exosomes Biomimetic Therapy.
https://www.nouveau-visage.com/produit/newderm-age-control/ - Zhang Y, Liu Y, Liu H, Tang WH. Exosomes: Biogenesis, Biologic Function, and Clinical Potential. Cell & Bioscience. 2019.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6397026/ - Cavallini M et al. Polynucleotides in Aesthetic Medicine. Aesthetic Medicine. 2018.
https://pubmed.ncbi.nlm.nih.gov/30382454/ - Juhász MLW, Cohen JL. The Science of Hyaluronic Acid Fillers. Aesthetic Surgery Journal. 2020.
https://pubmed.ncbi.nlm.nih.gov/32678804/ - Schagen SK. Topical Peptides in Anti-Aging Skin Care. Cosmetics. 2017; 4(2):16.
https://www.mdpi.com/2079-9284/4/2/16 - Kalluri R, LeBleu VS. The Biology, Function, and Biomedical Applications of Exosomes. Science. 2020; 367(6478):eaau6977.
https://www.science.org/doi/10.1126/science.aau6977 - Gurunathan S et al. Current Trends in Therapeutic Application of Exosomes in Regenerative Medicine. Int J Nanomedicine. 2021; 16:75–106.
https://pmc.ncbi.nlm.nih.gov/articles/PMC7816837/